Latham & Watkins and NautaDutilh advised Merus on the offering. Merus N.V., an oncology company in the clinical stage, successfully raised an estimated USD 460 million...
You must be a Standard 1 Year member to access this content.
NautaDutilh assisted NewAmsterdam with their underwritten offering of ordinary shares and pre-funded warrants on Nasdaq. NewAmsterdam (Nasdaq: NAMS), a late-stage biopharmaceutical company focused on developing transformative...
You must be a Standard 1 Year member to access this content.
NautaDutilh assisted Pharvaris with underwritten offering. Pharvaris successfully completed an underwritten offering of ordinary shares and pre-funded warrants at an offer price of USD 24 per...
You must be a Standard 1 Year member to access this content.
Covington and NautaDutilh advised NewAmsterdam Pharma on the deal, while Latham & Watkins advised Lincoln International. Houthoff assisted Frazier Lifesciences Acquisition Corp. NewAmsterdam Pharma Holding B.V.,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP and Loyens & Loeff advised Lauxera Capital Partners on the deal, while NautaDutilh assisted LUMICKS Technologies B.V. Lauxera Capital Partners announced their investment...
You must be a Standard 1 Year member to access this content.
